- Report
- August 2025
- 367 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- January 2025
- 148 Pages
Global
From €2795EUR$3,160USD£2,413GBP
€3493EUR$3,950USD£3,016GBP
- Report
- February 2025
- 185 Pages
Global
From €4112EUR$4,650USD£3,550GBP
- Report
- August 2025
- 182 Pages
Global
From €3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 194 Pages
Global
From €3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 180 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 199 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 183 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 189 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- May 2025
- 193 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- March 2025
- 148 Pages
Global
From €2652EUR$2,999USD£2,290GBP
- Report
- May 2025
- 220 Pages
Global
From €5262EUR$5,950USD£4,543GBP
- Report
- April 2025
- 120 Pages
Global
From €5262EUR$5,950USD£4,543GBP
- Report
- January 2025
- 282 Pages
Global
From €4422EUR$5,000USD£3,818GBP
- Report
- April 2025
- 204 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- August 2025
- 272 Pages
Global
From €5174EUR$5,850USD£4,467GBP

The Neurological Disorder market is a subset of the Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This includes conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. The market is composed of a variety of stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions.
The market is driven by the increasing prevalence of neurological disorders, as well as advances in technology and treatments. Pharmaceutical companies are developing new drugs to treat neurological disorders, while medical device manufacturers are creating innovative products to improve patient care. Healthcare providers are also playing an important role in providing diagnosis and treatment services.
Some companies in the Neurological Disorder market include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more